BACKGROUND: Ulcerative colitis (UC) and Crohn's disease (CD) can cause metabolic and inflammatory alterations. AIM: To evaluate the relationships between inflammatory parameters, plasma lipids and phospholipid fatty acid (FA) composition in patients with active UC and CD. METHODS: Diet, the Harvey-Bradshaw Activity Index (HBAI), inflammatory parameters, lipoproteins and FA composition were assessed in 60 CD and 34 UC. RESULTS: No differences in clinical parameters were observed in the two groups. Total cholesterol correlated inversely with the number of bowel movements in both groups and directly with BMI in UC. Arachidonic acid correlated inversely with HBAI in UC and total and HDL cholesterol were inversely related to C-reactiv...
Background: Inflammatory bowel disease is a group of pathologies characterised by chronic inflammati...
Background: Inflammatory bowel disease is a group of pathologies characterised by chronic inflammati...
Background: Ulcerative colitis is acommontype of inflammatory bowel disease (IBD). The aim of the pr...
Background: The relationships between lipid profiles and IBD remain elusive. Aim: To determine the...
Background and Aims: Ulcerative colitis (UC) is associated with increased dietary intake of fat and ...
Background - The onset of ulcerative colitis (UC) is associated with alterations in lipid metabolism...
Plasma fatty acid patterns were assessed by gas liquid chromatography in 73 patients with active inf...
Objectives: Ulcerative colitis (UC) is a relapsing inflammatory disorder of unconfirmed aetiology, v...
Ulcerative colitis (UC) is a relapsing inflammatory disorder of unconfirmed aetiology, variable seve...
BACKGROUND: A diminished antioxidant defence and alterations in the fatty acid profile may play a ro...
BACKGROUND: A diminished antioxidant defence and alterations in the fatty acid profile may play a ro...
Disruption of the lipid profile is commonly found in patients with inflammatory bowel disease (IBD)....
BACKGROUND: A diminished antioxidant defence and alterations in the fatty acid profile may play a ro...
BACKGROUND: A diminished antioxidant defence and alterations in the fatty acid profile may play a ro...
BACKGROUND: A diminished antioxidant defence and alterations in the fatty acid profile may play a ro...
Background: Inflammatory bowel disease is a group of pathologies characterised by chronic inflammati...
Background: Inflammatory bowel disease is a group of pathologies characterised by chronic inflammati...
Background: Ulcerative colitis is acommontype of inflammatory bowel disease (IBD). The aim of the pr...
Background: The relationships between lipid profiles and IBD remain elusive. Aim: To determine the...
Background and Aims: Ulcerative colitis (UC) is associated with increased dietary intake of fat and ...
Background - The onset of ulcerative colitis (UC) is associated with alterations in lipid metabolism...
Plasma fatty acid patterns were assessed by gas liquid chromatography in 73 patients with active inf...
Objectives: Ulcerative colitis (UC) is a relapsing inflammatory disorder of unconfirmed aetiology, v...
Ulcerative colitis (UC) is a relapsing inflammatory disorder of unconfirmed aetiology, variable seve...
BACKGROUND: A diminished antioxidant defence and alterations in the fatty acid profile may play a ro...
BACKGROUND: A diminished antioxidant defence and alterations in the fatty acid profile may play a ro...
Disruption of the lipid profile is commonly found in patients with inflammatory bowel disease (IBD)....
BACKGROUND: A diminished antioxidant defence and alterations in the fatty acid profile may play a ro...
BACKGROUND: A diminished antioxidant defence and alterations in the fatty acid profile may play a ro...
BACKGROUND: A diminished antioxidant defence and alterations in the fatty acid profile may play a ro...
Background: Inflammatory bowel disease is a group of pathologies characterised by chronic inflammati...
Background: Inflammatory bowel disease is a group of pathologies characterised by chronic inflammati...
Background: Ulcerative colitis is acommontype of inflammatory bowel disease (IBD). The aim of the pr...